Importance of Molecular Features of Non–Small Cell Lung Cancer for Choice of Treatment

American Journal of Pathology - United States
doi 10.1016/j.ajpath.2010.12.057
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Treatment Choice Based on Radiographic Features for Metastatic Brain Tumors in ALK-Rearranged Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Correlation of Neuroendocrine Features With Prognosis of Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Molecular Gene Signature and Prognosis of Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations

Oncologist
Cancer ResearchMedicineOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy